News

tb-media

Dr Burke’s Australia Day Honour puts multiple sclerosis in the spotlight

MS Australia congratulates Dr Therese Burke who has been honoured for her significant service to medicine, particularly multiple sclerosis research, and to nursing, by being made a Member of the Order of Australia (AM) in today’s 2023 Australia Day Honours List.
Red and white blood cells

Cladribine restricts immune cells from entering the brain

As well as depleting immune cells, new research shows cladribine (Mavenclad) may impede their movement into brain tissue, preventing further damage by multiple sclerosis.
Rohan Greenland The May 50K

From our CEO

MS Australia CEO Rohan Greenland answers the question, ‘what are the big breakthroughs that lie ahead?’ He details the latest research, treatments and programs that will propel us faster and further along the ‘pathways to cures’.  
Exploring the impact of diet quality on MS symptoms v2

Exploring the impact of diet quality on MS symptoms

Many people living with multiple sclerosis modify their dietary intake after their MS diagnosis, but there is little evidence that dietary modifications influence MS outcomes. A recent Australian study has explored the impact of diet quality specifically on three common MS symptoms; depression, anxiety and fatigue.
Clinical trials

You can take part in clinical trials and research studies!

The MS Australia Clinical Trials Network is a central point of information for people interested in participating in clinical trials and research studies in MS, or in finding out more details of studies in MS.
Ben Holgate

Having the will to help out at work

MS Plus employee Ben Holgate says he wants to give something back to the charity where he’s worked for the past five years.
Tysabri PBS submission

New form of Tysabri® under PBAC consideration

MS Australia will be making a submission advocating for the subcutaneous form of Tysabri® to be listed on the PBS, as we welcome affordable access to all treatment options that have been shown in clinical trials to provide safe and effective treatment for MS.
Rohan Greenland The May 50K

From our CEO

CEO Rohan Greenland reflects on the achievements over the past year and looks ahead to MS Australia’s goals for 2023, where our focus will remain tightly on supercharging MS research, advocacy, education and awareness.
Switching between MS therapies safely

Switching between MS therapies safely

What happens with MS when you stop a disease-modifying therapy, and what is the ideal time window for starting a new one?
MS risk proteins

Australian researchers discover potential MS risk proteins

Researchers supported by MS Australia have identified proteins that may be involved in multiple sclerosis susceptibility and disease progression.
MS represented on screen in new Netflix series

MS represented on screen in new Netflix series

Irreverent, a new ten-part crime drama television series airing on Netflix, sought early guidance from MS Australia regarding a character who lives with multiple sclerosis.
Gwen Gray

A pioneer with a passion for helping others

As a pioneering mechanical engineer, Gwen Gray was a visionary. Her kindness continues to have an impact beyond her years.
New types of clinical trials on the horizon for MS

New types of clinical trials on the horizon for MS

Adaptive clinical trials are new forms of clinical trials that are used to answer complex research questions more efficiently than traditional methods. When used in MS, adaptive clinical trials can deliver more effective therapies to people living with multiple sclerosis sooner, thereby protecting brain health.
John Studdy Award 2022

Award for decades of selfless service to people living with MS

MS Australia is honoured to announce Nigel Caswell as the recipient of the 2022 John Studdy Award in recognition of his commitment, dedication and service to people living with MS.
Rohan Greenland The May 50K

From our CEO

MS Australia CEO Rohan Greenland discusses the need for a national minimum neurological data set to ensure the 1.6m Australians living with these conditions can receive the resources and support required.
ECTRIMS 2022

Thousands of experts meet in Amsterdam to present the latest MS research

The European Committee for Treatment and Research in MS, seen as the pinnacle of scientific and medical research into multiple sclerosis, held its annual meeting in Amsterdam last month. This article provides an overview of some of the key highlights of the conference.
NEWS People with secondary progressive MS have distinct trajectories of disability progression

People with secondary progressive MS have distinct trajectories of disability progression

A large international study shows that people living with secondary progressive multiple sclerosis experience different progression trajectories.
Funding research for a brighter tomorrow

Funding research for a brighter tomorrow

Bronwyn spent her childhood watching her mother live with advancing MS. Then she was diagnosed with MS when she was just 25. Now, as a mother of two daughters, she looks to MS research to give her hope for a better tomorrow.

Newsletter subscription

  • Enter your details

Dr Burke’s Australia Day Honour puts multiple sclerosis in the spotlight